<div class="tabs">
    <a href="" ui-sref="PTCL" class="tab">ABOUT PTCL</a>
    <a href="" ui-sref="BELEODAQ" class="tab active">ABOUT BELEODAQ</a>
    <a href="" ui-sref="WORKS" class="tab">HOW BELEODAQ WORKS</a>
</div>
<section id="beleodaq">
    <h2 class="primary">BELEODAQ is one of many treatments for relapsed or refractory PTCL</h2>

    <div class="section-group">
        <img src="assets/images/about/about-beleodaq.png" alt="A doctor and patient consultation" />
        <div class="col">
            <p>Your options may include:<sup>4</sup></p>
            <ul>
                <li>Anticancer medicines, such as chemotherapy, immunomodulators, or targeted therapy, given alone (single-agent therapy) or in combination with other medicines</li>
                <li>Stem cell transplantation</li>
                <li>Clinical trials</li>
            </ul>
            <h3 class="secondary">BELEODAQ can help treat PTCL<sup>1</sup></h3>
            <p><strong>BELEODAQ (belinostat) is a prescription anticancer medicine that can help treat PTCL that returns or does not respond to other therapies.<sup>1</sup></strong> Your doctor may recommend BELEODAQ after you have tried other anticancer medicines.</p>
            <p>This indication is approved under accelerated approval based on tumor response rate and duration of response. An improvement in survival or disease-related symptoms has not been established. Continued approval for this indication may be contingent upon veriﬁcation and description of clinical beneﬁt in the conﬁrmatory trial.<sup>1</sup></p>

            <p>It is not known if BELEODAQ is safe and effective in children.<sup>1</sup></p>
        </div>
    </div>

    <div class="grad-box">
        <h3 class="secondary">When PTCL comes back or other treatments stop working, BELEODAQ may be an option for you.</h3>
        <h5>BELEODAQ is<sup>1</sup></h5>
        <ul>
            <li>An FDA-approved, single-agent treatment proven to stop cancer cells from growing in relapsed or refractory PTCL</li>
            <li>Effective against the most common subtypes of PTCL</li>
            <li>Well tolerated by patients previously treated with other anticancer medicines</li>
            <li>Dosed in a way that may give you time to do more with your day</li>
        </ul>
    </div>

    <h3 class="secondary">Ask your doctor if BELEODAQ fits into your PTCL treatment plan.</h3>

    <a href="" ui-sref="WORKS" class="next-btn">Next: How BELEODAQ Works <i class="fas fa-chevron-right"></i></a>
</section>